Clinical Scorecard: Concerns Rise Among Physicians Regarding the Surge in Congenital Syphilis Cases
At a Glance
Category
Detail
Condition
Key Mechanisms
Failure of local public health programs, missed screening and treatment in pregnant women, barriers such as lack of insurance and fear of immigration detention.
Target Population
Care Setting
Key Highlights
Nearly 4,000 new cases of congenital syphilis reported in 2024, highest since the mid-1950s.
80% of pregnant women receiving prenatal care are tested for syphilis.
Immediate treatment upon positive screening is recommended.
Shortages of injectable penicillin pose challenges for treatment.
Integration of maternal health and substance use treatment is essential.
Guideline-Based Recommendations
Diagnosis
Routine syphilis screening for all pregnant women.
Use of rapid point-of-care tests in various settings.
Management
Immediate treatment with injectable benzathine penicillin G upon positive screening.
Expand who can administer injectable penicillin to include trained nurses and pharmacists.
Monitoring & Follow-up
Real-time monitoring of screening rates and treatment timeliness.
Regular performance target reporting.
Risks
Missed screening and treatment can lead to stillbirths and lifelong disabilities.
Patient & Prescribing Data
Pregnant women at risk for syphilis.
Same-day treatment with injectable penicillin is critical.
Clinical Best Practices
Ensure availability of injectable penicillin in clinics.
Expand who can administer injectable penicillin.
Implement reminder prompts in electronic health records.
Engage in real-time monitoring and accountability.
